LIGAND PHARMACEUTICALS INC
SEC insider (Form 3/4/5 filer). CIK 0000886163. 10% Owner at Pelthos Therapeutics Inc. (PTHS). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in JUPITER, FL.
Companies LIGAND PHARMACEUTICALS INC has filed insider reports for
- Pelthos Therapeutics Inc. (PTHS): 10% Owner
LIGAND PHARMACEUTICALS INC
CIK: 0000886163
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Pelthos Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 17, 2025PTHS
Pelthos Therapeutics Inc.
DispositionDirectSenior Secured Convertible Note
0 shares- - Dec 17, 2025PTHS
Pelthos Therapeutics Inc.
AwardDirectSenior Secured Convertible Note
0 shares- - Nov 6, 2025PTHS
Pelthos Therapeutics Inc.
AwardDirectSenior Secured Convertible Note
0 shares at avg. $9000000.00- - Jul 1, 2025PTHS
Pelthos Therapeutics Inc.
ConversionDirect1.5M shares at avg. $10.00$15.0M - Jul 1, 2025PTHS
Pelthos Therapeutics Inc.
OtherDirectSeries A Convertible Preferred Stock
31.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 17, 2025 | PTHS Pelthos Therapeutics Inc. | Disposition Senior Secured Convertible Note | 0 | - | - | Direct |
| Dec 17, 2025 | PTHS Pelthos Therapeutics Inc. | Award Senior Secured Convertible Note | 0 | - | - | Direct |
| Nov 6, 2025 | PTHS Pelthos Therapeutics Inc. | Award Senior Secured Convertible Note | 0 | $9000000.00 | - | Direct |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | Conversion | 1,500,000 | $10.00 | $15,000,000 | Direct |
| Jul 1, 2025 | PTHS Pelthos Therapeutics Inc. | Other Series A Convertible Preferred Stock | 31,279 | - | - | Direct |
1-5 of 5 transactions